Skip to main content

GOLDMAN SACHS GROUP INC

Position in RDY — Dr Reddys Laboratories Ltd

CIK 886982 NEW YORK, NY

Position in RDY

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$8,349,278
+$3,860,410 QoQ
Shares Held
602,836
+88.6% QoQ
Ownership
0.072%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RDY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $1,741,757,397 across 53 Drug Manufacturers - Specialty & Generic names. RDY ranks #28 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RDY

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $8,349,278 602,836
2025-12-31 $4,488,868 319,720
2025-09-30 $9,722,739 695,475
2025-06-30 $9,728,256 647,256
2025-03-31 $2,904,081 220,173
2024-12-31 $19,292,616 1,221,825
2024-09-30 $44,176,979 556,035
2024-06-30 $74,909,321 983,191
2024-03-31 $114,362,037 1,559,128
2023-12-31 $127,829,800 1,837,163
2023-09-30 $132,238,633 1,977,548
2023-06-30 $61,237,714 970,333
2023-03-31 $42,921,746 753,939
2022-12-31 $38,126,035 736,735
2022-09-30 $53,274,058 1,017,846
2022-06-30 $41,127,018 742,499
2022-03-31 $41,490,148 744,485
2021-12-31 $36,409,822 556,640
2021-09-30 $41,364,551 635,010
2021-06-30 $34,274,258 466,253
2021-03-31 $24,277,534 395,464
2020-12-31 $58,842,051 825,390
2020-09-30 $92,079,074 1,323,736
2020-06-30 $75,704,639 1,428,120
2020-03-31 $48,377,164 1,199,533